A randomized, double-blind, placebo-controlled trial of repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis

Ítems similars

• Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
  per: Alton, EWFW, et al.
  Publicat: (2015)
• SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF
  per: Davies, J, et al.
  Publicat: (2011)
• Self-reactive CFTR T cells in humans: implications for gene therapy.
  per: Calcedo, R, et al.
  Publicat: (2013)
• SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
  per: Davies, G, et al.
  Publicat: (2011)
• A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
  per: Alton, EWFW, et al.
  Publicat: (2016)